An extraction pipeline for analysis of hematopoietic stem cell transplantation data
Authors:
- Erik G. J. von AsmuthEAErik G. J. von Asmuth
- Jurjen VersluisJVJurjen Versluis
- Emanuele AngelucciEAEmanuele Angelucci
- Ali BazarbachiAli Bazarbachi
- Fabio CiceriFCFabio Ciceri
- Raffaella GrecoRGRaffaella Greco
- Krzysztof KałwakKKKrzysztof Kałwak
- Donal P. McLornanDMDonal P. McLornan
- Bénédicte NevenBNBénédicte Neven
- 10 March 2026
- journal article
- technical report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 61 (4) , 400-407
Abstract
Many clinical studies are based on registry analyses, but exact approaches of data extraction and pre-processing are rarely included, while this is critical for reliability and reproducibility of results. We aimed to develop an open-source data extraction pipeline which generates a ready-to-analyze dataset focused on relevant determinants of outcomes after hematopoietic stem cell transplantation (HSCT). This pipeline was developed using EBMT registry data, including 54,457 allogeneic and 63,651 autologous HSCT procedures. The pipeline determines HLA matching from molecular data, assesses cytogenetic risk for acute myeloid leukemia and myelodysplastic syndrome, processes molecular markers, assigns the hematopoietic cell transplantation comorbidity index (HCT-CI) based on comorbidities, and maps disease states to simplified categories. We prospectively assessed the recently developed disease risk stratification system (DRSS), showing that the pipeline produces consistent results with previous studies. The hazard ratio correlation between our cohort and the original DRSS derivation cohort was 0.92 with a 2-year AUC of 0.616, indicating similar effects and predictive performance. We aim to establish a new standard by promoting transparent, standardized and uniform extraction of registry data, enhancing reproducibility in registry studies.Keywords
This publication has 28 references indexed in Scilit:
- HLA structure and function in hematopoietic-cell transplantationBest Practice & Research Clinical Haematology, 2024
- The role of registries in hematological disordersBest Practice & Research Clinical Haematology, 2024
- Handling missing covariate data in clinical studies in haematologyBest Practice & Research Clinical Haematology, 2023
- Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)Bone Marrow Transplantation, 2023
- Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity SurveyBone Marrow Transplantation, 2023
- A clinician’s guide to HLA matching in allogeneic hematopoietic stem cell transplantHuman Immunology, 2022
- Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registryThe Lancet Haematology, 2021
- The EBMT Handbook2019
- Fanconi anemia and the development of leukemiaBest Practice & Research Clinical Haematology, 2014
- Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsBone Marrow Transplantation, 2014